In a dramatic turn of events, Reckitt Benckiser Group plc finds itself embroiled in a class action lawsuit that could have significant repercussions for the company and its shareholders. The lawsuit, filed against the multinational consumer goods giant, alleges that Reckitt misled investors about the safety of its Enfamil infant formula and the potential financial fallout. Between January 13, 2021, and July 28, 2024, Reckitt is accused of making false statements regarding the risk of preterm infants developing necrotizing enterocolitis (NEC) from consuming its cow’s milk-based formula, Enfamil. This alleged misinformation is said to have masked the true impact on Reckitt’s sales and its exposure to legal claims, painting an overly optimistic picture of the company’s business prospects.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
For shareholders who suffered losses during this period, there is a path to recovery. Whether you still hold your shares or not, you can explore your rights and potential compensation by visiting the provided link. Importantly, there is no cost or obligation to participate in this legal action.
Levi & Korsinsky LLP is dedicated to representing all plaintiffs seeking justice in this case. With over two decades of experience in securities litigation, the firm has a proven track record of securing substantial settlements for investors. Their expertise in handling complex cases makes them a formidable force in this high-stakes legal battle.
If you believe you have been affected, don’t hesitate to take action. Visit the link to learn more about your rights and how you can participate in this class action lawsuit.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171